News | March 17, 2023
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)